BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.260
-0.210 (-6.05%)
At close: Jul 2, 2026, 4:00 PM EDT
3.396
+0.136 (4.16%)
After-hours: Jul 2, 2026, 7:57 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $28.46 million as of July 2, 2026. Its market cap has increased by 34.86% in one year.
Market Cap
28.46M
Enterprise Value
5.95M
1-Year Change
34.86%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $28.46M, an increase of 9.45%. That is a compound annual growth rate of 1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 28.46M | 112.36% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 30.75M |
| Kyntra Bio | 30.60M |
| Plus Therapeutics | 30.08M |
| Serina Therapeutics | 29.10M |
| IGC Pharma | 27.22M |
| Barinthus Biotherapeutics | 26.96M |
| Evaxion | 25.85M |
| NeuroSense Therapeutics | 25.45M |